Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1962 2
1963 3
1965 3
1966 5
1967 3
1968 3
1969 1
1970 1
1975 1
1976 1
1977 2
1978 1
1981 1
1985 1
1991 1
1994 1
1995 1
1996 1
1997 1
2001 1
2002 3
2003 2
2004 1
2005 1
2006 3
2007 1
2008 1
2009 3
2010 3
2014 2
2016 2
2017 3
2018 4
2019 3
2020 7
2021 16
2022 11
2023 10
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial.
Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM; Exceptional Responders Clinical Trials Group. Kuerer HM, et al. Lancet Oncol. 2022 Dec;23(12):1517-1524. doi: 10.1016/S1470-2045(22)00613-1. Epub 2022 Oct 25. Lancet Oncol. 2022. PMID: 36306810 Clinical Trial.
Stand-Alone Machine Learning: More Work Is Needed.
Whitman GJ, Moseley TW. Whitman GJ, et al. Among authors: moseley tw. Radiology. 2022 Jan;302(1):105-106. doi: 10.1148/radiol.2021211885. Epub 2021 Oct 19. Radiology. 2022. PMID: 34665035 No abstract available.
Identifying and Reducing Barriers to Breast Imaging.
Jean S, Vishwanath V, Chung HL, Moseley TW. Jean S, et al. Among authors: moseley tw. Curr Breast Cancer Rep. 2023;15(2):114-118. doi: 10.1007/s12609-023-00480-8. Epub 2023 Apr 5. Curr Breast Cancer Rep. 2023. PMID: 37293273 Free PMC article. Review.
Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.
Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma J. Zhou Z, et al. Among authors: moseley tw. Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10340987. Annu Int Conf IEEE Eng Med Biol Soc. 2023. PMID: 38083160
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial.
Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM; Exceptional Responders Study Group. Johnson HM, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2333933. doi: 10.1001/jamanetworkopen.2023.33933. JAMA Netw Open. 2023. PMID: 37707811 Free PMC article. Clinical Trial.
Interleukin-17 family and IL-17 receptors.
Moseley TA, Haudenschild DR, Rose L, Reddi AH. Moseley TA, et al. Cytokine Growth Factor Rev. 2003 Apr;14(2):155-74. doi: 10.1016/s1359-6101(03)00002-9. Cytokine Growth Factor Rev. 2003. PMID: 12651226 Review.
Malignancies masquerading as device pocket infections.
Moseley T, Birgersdotter-Green U, Feld G, Pollema T. Moseley T, et al. HeartRhythm Case Rep. 2021 Jul 31;7(10):694-697. doi: 10.1016/j.hrcr.2021.07.009. eCollection 2021 Oct. HeartRhythm Case Rep. 2021. PMID: 34712568 Free PMC article. No abstract available.
104 results